Co-creation is not a buzzword. How Pharma teams can make it work (with a little help from AI)
How do you future-proof your engagement strategy without falling back on the same old tactics? One insight stood out: co-creation is no longer optional.
How do you future-proof your engagement strategy without falling back on the same old tactics? One insight stood out: co-creation is no longer optional.
A panel with some of the most actionable advice that Pharma customer engagement managers could have right now. AI won’t do the whole job
How artificial intelligence is transforming pharmaceutical development, manufacturing, and patient care
Interview with Vivek Mukhatyar, Generative AI Medical Engagement Lead, Pfizer
Interview with Alexandros Athanasiou, Head of Marketing, Innovation and Excellence with Takeda Pharmaceuticals
Loucif Ouyahia, Global Head of Digital Healthcare, Jazz Pharmaceuticals | Managing expectations and countering ‘ChatGPT syndrome’
The Power of polyintelligence: A synergistic symphony of human and artificial intelligence
New tech combining forensic linguistics and machine learning yields surprising insights into what does and doesn’t work in HCP communication
New tech combining forensic linguistics and machine learning yields surprising insights into what does and doesn’t work in HCP communication
New tech combining forensic linguistics and machine learning yields surprising insights into what does and doesn’t work in HCP communication